SCHEMBL7501400

SCHEMBL7501400

COc1cccc(Cl)c1-c1oc(Cc2ccccc2)nc1-c1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.47
CA1 P00915 7/20 0.47
PTGS2 P35354 10/20 0.43
PTGS1 P23219 7/20 0.43
CA9 Q16790 4/20 0.41
CA12 O43570 3/20 0.41
CA14 Q9ULX7 2/20 0.41
RXRA P19793 1/20 0.40
LMNA P02545 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
MT-CO2 P00403 1/20 0.38
CA3 P07451 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
CYP3A4 P08684 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CHRM1 P11229 1/20 0.38
ADRA2B P18089 1/20 0.38
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7506645 0.93 CA2 (0.52) CA2CA1PTGS2PTGS1CA9
SCHEMBL7501945 0.93 CA2 (0.47) CA2CA1PTGS2PTGS1CA9
SCHEMBL7512154 0.91 PTGS2 (0.43) PTGS2PTGS1RXRALMNAALDH1A1
SCHEMBL7508608 0.90 CA1 (0.48) CA2CA1PTGS2PTGS1CA9
SCHEMBL7504101 0.89 CA2 (0.47) CA2CA1PTGS2PTGS1CA9
SCHEMBL7509766 0.88 CA1 (0.44) CA2CA1PTGS2PTGS1CA9
SCHEMBL7506477 0.87 CA2 (0.52) CA2CA1PTGS2PTGS1CA9
SCHEMBL7498727 0.86 PTGS2 (0.44) CA2CA1PTGS2PTGS1CA9
SCHEMBL7505718 0.86 PTGS2 (0.54) CA2CA1PTGS2PTGS1CA9
SCHEMBL7509612 0.85 RXRA (0.55) CA2CA1PTGS2PTGS1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO disclosed